Author:
Almquist Joachim,Wallman Mikael,Jacobson Ingemar,Jirstrand Mats
Reference34 articles.
1. IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation;Tamargo;Expert Opin. Investig. Drugs,2009
2. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current;Lagrutta;J. Pharmacol. Exp. Ther.,2006
3. Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation;Wettwer;Circulation,2004
4. “Early” class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat;Blaauw;Circulation,2004
5. Electrophysiological and antiarrhythmic effects of the novel IKur channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the IKr blockers dofetilide, azimilide, D,L-sotalol and ibutilide;Knobloch;Naunyn Schmiedebergs Arch. Pharmacol.,2002
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献